U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514143) titled 'Bladder EpiCheck Product Development Study' on March 30.
Brief Summary: This is a prospective, observational study to support the development of the Bladder EpiCheck kit by collecting urine samples from subjects suspected to have a bladder tumor or under NMIBC surveillance.
This is a single visit study. Each subject will sign the informed consent and provide voided urine sample. Demography and, if performed, pathology information will be collected for each subject.
Study Start Date: Sept. 15, 2025
Study Type: OBSERVATIONAL
Condition:
Suspicion of Bladder Cancer
NMIBC Surveillance
Intervention:
DIAGNOSTIC_TEST: Bladder EpiChec...